Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 3:19:1311-1316.
doi: 10.12659/AJCR.911236.

Brugada Syndrome Manifesting Only During Fever in Patient with Septic Shock Secondary to Post-Obstructive Pneumonia

Affiliations
Review

Brugada Syndrome Manifesting Only During Fever in Patient with Septic Shock Secondary to Post-Obstructive Pneumonia

Kristopher S Pfirman et al. Am J Case Rep. .

Abstract

BACKGROUND Brugada syndrome is a cardiac disorder associated with sudden death due to sodium channelopathy, most commonly the SCN5a mutation. There are 3 different patterns of electrocardiogram (ECG) changes characterized as type I, II, and III. ECG patterns consist of variations of incomplete RBBB and ST elevation in anterior precordial leads only. Treatment, if warranted, consists of implantable cardioverter-defibrillator. CASE REPORT A 63-year-old male presented with abdominal pain for 4 days that was persistent, and after further imaging, he was found to have hepatic metastases from a stage IV small cell carcinoma of the lung. The patient was started on chemotherapy with carboplatin and VP-16. The patient decompensated, developed septic shock secondary to post-obstructive pneumonia, and eventually required intubation. He became tachycardic, and an ECG was ordered to evaluate the heart rhythm. It was determined that the patient had Brugada wave/syndrome. The patient's condition deteriorated with worsening septic shock, suspected type II NSTEMI, and multiorgan failure. The patient was designated DNR ("do not resuscitate") and passed away. CONCLUSIONS This case represents how channelopathies can be provoked with fever. It is believed that this occurs due to denaturing of the ion channel leading to abnormal ST segment changes typically seen on ECG and an increased risk of developing lethal arrhythmias. Spontaneous presentation of nondrug-induced Brugada syndrome carries an increased risk of deadly arrhythmia, for which this patient would have required electrophysiological studies. Unfortunately, this patient was unable to undergo genetic testing or electrophysiological studies, as he passed away.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Conflicts of interest

None.

Figures

Figure 1.
Figure 1.
This is the ECG obtained when the patient was febrile and tachycardic. The elevated J point, seen in the septal leads only and designated by the arrows, is characteristic of Brugada wave. Full interpretation of the ECG was as follows: rate was 132; rhythm was sinus; axis was ∼60; PR was normal; QRS was Brugada in septal leads, type 1; ST, elevation in V1–V3; QRS Brugada without LBBB or RBBB or incomplete block; hypertrophy was none; P wave was no atrial enlargement; QRS wave was narrow; T wave was blunted but no deflection; U wave was absent; J point was maximum at 4 mm. Type 1 Brugada syndrome, QTc was 445.
Figure 2.
Figure 2.
This is the ECG obtained after the patient’s fever had resolved. As you can see, the Brugada wave is no longer present. Complete interpretation is as follows: rate was 99; rhythm was sinus; axis was ∼60 degrees; QRS was incomplete RBBB; PR was normal; QRS was not prolonged; hypertrophy was none; P wave was left atrial enlargement; QRS wave was no elongation; T wave was no abnormality; U wave was not present; J point was not elevated.

Similar articles

Cited by

References

    1. Escárcega RO, Jiménez-Hernández M, Garcia-Carrasco M, et al. The Brugada syndrome. Acta Cardiol. 2009;64(6):795–801. - PubMed
    1. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugadasyndrome. J Cardiovasc Electrophysiol. 2000;11(12):1320–29. - PubMed
    1. Brugada R, Campuzano O, Sarquella-Brugada G, et al. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–2017. Available From http://www.ncbi.nlm.nih.gov/books/NBK1517/
    1. Brugada R, Campuzano O, Sarquella Brugada G, et al. Brugada syndrome. Methodist Debakey Cardiovasc J. 2014;10(1):25–28. - PMC - PubMed
    1. Behr ER, Ensam B. Fever vs. drug: Battling with the Brugada syndrome substrate. Heart Rhythm. 2017;14(4):518–19. - PubMed

MeSH terms